Antisense & RNAi Technology Market Research Reports & Industry Analysis
Antisense and RNAi technology has the potential to influence gene expression, offering new possibilities for treating previously challenging diseases. Staying informed about this evolving field is crucial, and MarketResearch.com's reports on the antisense and RNAi technology industry are valuable resources. These reports offer in-depth analyses of industry trends, challenges, and opportunities to help stakeholders make well-informed decisions based on accurate information.
Comprehensive Antisense and RNAi Technology Research
- Find research on a wide spectrum of key market segments including reagents, consumables, RNAi drug delivery, and RNAi therapeutics.
- Gain a holistic view of the industry by delving into RNAi market sizing, growth trajectories, technological breakthroughs, and competitor strategies.
- Understand the trends that are shaping the antisense and RNAi technology industry to stay ahead of the curve in an environment characterized by change.
Why Choose MarketResearch.com
Whether you're a busy executive or a professional in the field, our antisense and RNAi technology market research reports are designed to meet your information needs. These reports offer reliable data to support your business decisions and help you take advantage of emerging market opportunities. Embrace the value of knowledge and confidently explore the potential of the antisense and RNAi technology industry with MarketResearch.com.
Antisense & RNAi Technology Industry Research & Market Reports
-
United Kingdom Rna Interference (Rnai) Drug Delivery Market Forecast 2024-2032
... is set to reach a revenue of $20807.84 million by 2032. MARKET INSIGHTS The United Kingdom RNA interference (RNAi) drug delivery market is witnessing a notable surge in demand, primarily driven by the increasing adoption ... Read More
-
South Korea Rna Interference (Rnai) Drug Delivery Market Forecast 2024-2032
... is set to reach a revenue of $6901.97 million by 2032. MARKET INSIGHTS The South Korea RNA interference (RNAi) drug delivery market is witnessing growth and interest due to several key factors. One of these ... Read More
-
Global Rna Interference (Rnai) Drug Delivery Market Forecast 2024-2032
... CAGR of 22.24% during the forecast period. The base year considered for the study is 2023, and the estimated period is between 2024 and 2032. The RNAi technology has emerged as a promising therapeutic approach, ... Read More
-
Global RNAi for Therapeutic Competitive Landscape Professional Research Report 2024
... RNAi is a mechanism where small RNA molecules, such as small interfering RNA (siRNA) or microRNA (miRNA), interfere with the translation or stability of specific messenger RNA (mRNA) molecules, thereby preventing the synthesis of a ... Read More
-
Biologics Market by Source (Mammalian, Microbial), Product (Antisense & RNAi Therapeutics, Monoclonal Antibodies, Recombinant Hormones or Proteins), Indication, End-user - Global Forecast 2024-2030
... and expected to reach USD 430.59 billion in 2024, at a CAGR 6.39% to reach USD 626.34 billion by 2030. Biologics are integral to the biomedical sector, focusing on developing, manufacturing, and distributing biological treatments ... Read More
-
RNAi Technology Market Size, Share & Trends Analysis Report By Product & Services (Products, Services), By Application (Drug Discovery & Development, Functional Genomics), By End-use, By Region, And Segment Forecasts, 2024 - 2030
... Market Growth & Trends The global RNAi technology market size is anticipated to reach USD 6.65 billion by 2030 and is growing at a CAGR of 14.6% from 2024 to 2030, according to a new ... Read More
-
Antisense and RNAi Therapeutics Market – Technology (RNA Interference, Antisense RNA), Route of Administration (Intrathecal, Intravenous, Subcutaneous), Application (Neurodegenerative, Cancer, Skin, Genetic Disorders) – Global Forecast (2024 – 2032)
... will grow at an 18.2% CAGR during 2024 and 2032, propelled by growing research and development coupled with the expansion of clinical trials. Continuous R&D efforts lead to the discovery of innovative therapies and improvements ... Read More
-
RNA Therapeutics Market Assessment, By Type [RNA Interference Therapeutics, mRNA Therapeutics, Antisense Oligonucleotide Therapeutics, Others], By Product [Vaccines, Drugs], By Indication [Rare Genetic Diseases/Hereditary Diseases, Infectious Diseases, Others], By End-user [Hospitals, Academic Research Centers, Contract Research Organizations, Others], By Region, Opportunities and Forecast, 2017-2031F
... Research Organizations, Others], By Region, Opportunities and Forecast, 2017-2031F Global RNA therapeutics market size was valued at USD 23,067.85 million in 2023, expected to reach USD 54,464.95 million in 2031, with a CAGR of 11.25% ... Read More
-
Global RNAi Therapeutics Market (by Molecule Type, Application, End-User & Region): Insights & Forecast with Potential Impact of COVID-19 (2024-2028)
... 2028, progressing at a CAGR of 10.02%, over the period 2024-2028. Factors such as rising utilization in oncology pharmaceuticals, accelerating growth rates of infectious diseases, enlarging geriatric population, increasing prevalence of neurodegenerative disorders and progress ... Read More
-
Global Oligonucleotide Therapeutics Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Biopharmaceutical Contract Manufacturing Market Size, Trends, Analysis, and Outlook By Product (Biologics, Monoclonal Antibodies (MABs), Recombinant Proteins, Vaccines, Antisense, RNAi & Molecular Therapy, Biosimilars), By Source (Mammalian, Non-Mammalian), By Service (Process Development, Fill And Finish Operations, Analytical And QC Studies, Packaging), By Application (Clinical, Commercial), by Country, Segment, and Companies, 2024-2032
... Operations, Analytical And QC Studies, Packaging), By Application (Clinical, Commercial), by Country, Segment, and Companies, 2024-2032 The global Biopharmaceutical Contract Manufacturing market size is poised to register 8.3% growth from 2024 to 2032, presenting significant ... Read More
-
RNA Therapeutics Market Size, Trends, Analysis, and Outlook By Product (Vaccines, Drugs), By Type (mRNA Therapeutics, RNA Interference (RNAi) Therapeutics, Antisense Oligonucleotide (ASO) Therapeutics, Others), By Indication (Infectious Diseases, Rare Genetic Diseases/Hereditary Diseases, Others), By End-User (Hospitals and Clinics, Research Settings), by Country, Segment, and Companies, 2024-2032
... End-User (Hospitals and Clinics, Research Settings), by Country, Segment, and Companies, 2024-2032 The global RNA Therapeutics market size is poised to register 8.9% growth from 2024 to 2032, presenting significant growth prospects for companies operating ... Read More
-
Gene Editing Market Size, Trends, Analysis, and Outlook By Products and Services (Reagents & Consumables, Software & Systems, Services), By Technology (CRISPR, TALEN, ZFN, ANTISENSE, Others), By Application (Cell Line Engineering, Genetic Engineering, Drug Discovery & Development, Others), By End-User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Others), by Country, Segment, and Companies, 2024-2032
... & Development, Others), By End-User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Others), by Country, Segment, and Companies, 2024-2032 The global Gene Editing market size is poised to register 16.5% growth from 2024 to ... Read More
-
Global siRNA Drug Market Report, History and Forecast 2023-2029
... million by 2030, growing at a CAGR of 31.94% during the forecast period 2024-2030. United States market for siRNA Drug was valued at $ 902.04 million in 2023 and will reach $ 5,220.55 million by ... Read More
-
Olpasiran Market Size, Forecast, and Emerging Insight − 2032
... of the olpasiran for myocardial infarction in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 –2032 is provided in this ... Read More
-
Oligonucleotides: Global Markets
... for oligonucleotide synthesis is divided into research and diagnostics and therapeutics. By geography, the market in this report is divided into four regions: North America, Europe, Asia-Pacific, and Rest of the World (RoW). For market ... Read More
-
Global RNAi for Therapeutic Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028
... growth of the RNAi for Therapeutic industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of RNAi for Therapeutic. The report also introduces players ... Read More
-
Oligonucleotide Therapeutics Market Size, Trends, Analysis, and Outlook By Type (Antisense, Ribozymes, Aptamers, Mirna, Cpg/Immunostimulatory, RNAi), By Application (Infectious Diseases, Oncology, Neurodegenerative Disorders, Cardiovascular Diseases, Kidney Diseases, Others), by Region, Country, Segment, and Companies, 2024-2030
... The global Oligonucleotide Therapeutics market size is poised to register 9.41% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Oligonucleotide Therapeutics ... Read More
-
RNAi Drug Delivery Market Size, Trends, Analysis, and Outlook By Technology (Nanoparticle drug delivery, Pulmonary drug delivery, Nucleic acid drug delivery, Aptamer drug delivery), By Application (Infectious diseases, Oncology, Cardiology, Neurology, Others), by Region, Country, Segment, and Companies, 2024-2030
... Segment, and Companies, 2024-2030 The global RNAi Drug Delivery market size is poised to register 17.5% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study ... Read More
-
RNAi Technology Market Size, Trends, Analysis, and Outlook By Application (Drug Discovery and Development , Therapeutics (Oncology, Ocular Disorders, Respiratory Disorders, Hepatitis, Neurological Disorders, Others)), by Region, Country, Segment, and Companies, 2024-2030
... Technology market size is poised to register 16.24% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global RNAi Technology market By Application ... Read More
-
Antisense and RNAi Therapeutics Market Size, Trends, Analysis, and Outlook By Technology (RNA Interference, Antisense RNA), By Application (Ocular, Cardiometabolic & Renal Disorders, Cancer, Respiratory Disorders, Skin Diseases, Neurodegenerative Disorders, Genetic Disorders, Infectious Diseases, Others), By Route of Administration (Intravenous Injections, Intrathecal Injections, Subcutaneous Injections, Others), by Region, Country, Segment, and Companies, 2024-2030
... By Route of Administration (Intravenous Injections, Intrathecal Injections, Subcutaneous Injections, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Antisense and RNAi Therapeutics market size is poised to register 9.24% growth from 2024 to ... Read More
-
Viral Vector Contract Development Manufacturing Organizations Market Size, Trends, Analysis, and Outlook By Vector (Adenovirus, Retrovirus, Adeno-Associated Virus, Lentivirus, Others), By Workflow (Upstream Manufacturing, Downstream Manufacturing), By Application (Antisense & RNAi Therapy, Gene Therapy-, Cell Therapy, Vaccinology, Research Applications), By End-user (Pharmaceutical & Biopharmaceutical Companies, Research Institutes), by Region, Country, Segment, and Companies, 2024-2030
... Therapy, Vaccinology, Research Applications), By End-user (Pharmaceutical & Biopharmaceutical Companies, Research Institutes), by Region, Country, Segment, and Companies, 2024-2030 The global Viral Vector Contract Development Manufacturing Organizations market size is poised to register 14.5% growth ... Read More
-
Viral Vectors and Plasmid DNA Manufacturing Market Size, Trends, Analysis, and Outlook By Type (Adenovirus, Retrovirus, Adeno-Associated Virus (AAV), Lentivirus, Plasmids, Others), By Manufacturing (Upstream Manufacturing (Vector Amplification & Expansion, Vector Recovery/Harvesting), Downstream Manufacturing (Purification, Fill Finish)), By Application (Antisense & RNAi Therapy, Gene Therapy, Cell Therapy, Vaccinology, Research Applications), By End-user (Pharmaceutical and Biopharmaceutical Companies, Research Institutes), By Disease (Cancer, Genetic Disorders, Infectious Diseases, Others), by Region, Country, Segment, and Companies, 2024-2030
... Fill Finish)), By Application (Antisense & RNAi Therapy, Gene Therapy, Cell Therapy, Vaccinology, Research Applications), By End-user (Pharmaceutical and Biopharmaceutical Companies, Research Institutes), By Disease (Cancer, Genetic Disorders, Infectious Diseases, Others), by Region, Country, Segment, ... Read More
-
RNA Therapy Clinical Trials Market Size, Trends, Analysis, and Outlook By Modality (RNA interference, Antisense therapy, Messenger RNA, Oligonucleotide, non-antisense, non-RNAi), By Phase (Phase I, Phase II, Phase III, Phase IV), By Therapeutic Area (Rare Diseases, Anti-infective, Anticancer, Neurological, Alimentary/Metabolic, Musculoskeletal, Cardiovascular Respiratory, Sensory, Others), by Region, Country, Segment, and Companies, 2024-2030
... Diseases, Anti-infective, Anticancer, Neurological, Alimentary/Metabolic, Musculoskeletal, Cardiovascular Respiratory, Sensory, Others), by Region, Country, Segment, and Companies, 2024-2030 The global RNA Therapy Clinical Trials market size is poised to register 6.14% growth from 2024 to 2030, ... Read More
-
Biologics Market Report by Source (Microbial, Mammalian, and Others), Product (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Antisense, RNAi and Molecular Therapy, and Others), Disease (Oncology, Immunological Disorders, Cardiovascular Disorders, Hematological Disorders, and Others), Manufacturing (Outsourced, In-House), and Region 2024-2032
... and Region 2024-2032 The global biologics market size reached US$ 349.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 699.5 Billion by 2032, exhibiting a growth rate (CAGR) of 7.8% ... Read More
Research Assistance
